US Packaging Company Boosts Market Cap by 5 Trillion Won with Strong Performance

Shares of West Pharmaceutical Services Inc. (NYSE: WST) surged 14.79% to $314.99 in New York trading on the 22nd, pushing its market capitalization up by nearly $3.9 billion to approximately $22.6 billion in a single day.

In its first-quarter 2026 results released on the 23rd, West reported revenue of $844.9 million, a 21% year-over-year increase, and adjusted diluted EPS of $2.13—well ahead of analysts’ expectations. The company subsequently raised its full-year revenue and EPS guidance. Following the earnings surprise and upgraded outlook, the stock gapped up from a prior close of $274.41 into the mid-$300s, marking an intraday gain of more than 10%.

Headquartered in Exton, Pennsylvania, West Pharmaceutical Services specializes in manufacturing injectable drug packaging and delivery systems for the pharmaceutical and biotech industries. It is structurally benefiting from rising demand for high-value injectables, including biologics and GLP-1 therapies. Serving major global drugmakers, West has expanded its portfolio to include premium stoppers, vials, and prefilled syringe components, positioning itself as a “hidden infrastructure” player in the biopharma supply chain.